Publications by authors named "Howard Roth"

Claim this Profile
I
Incidence and Significance of Hypermetabolic PET-CT Findings in Unilateral TVF Motion Impairment.
Luke Stanisce, Timothy Renzi, Nikita Paripati, Nadir Ahmad, Thomas C Spalla, Howard L Roth

Otolaryngol Head Neck Surg· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improving Abnormality Detection on Chest Radiography Using Game-Like Reinforcement Mechanics.
Po-Hao Chen, Howard Roth, Maya Galperin-Aizenberg, Alexander T Ruutiainen, Warren Gefter

Acad Radiol· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synergistic and targeted therapy with a procaspase-3 activator and temozolomide extends survival in glioma rodent models and is feasible for the treatment of canine malignant glioma patients.
Avadhut D Joshi, Rachel C Botham, Lisa J Schlein, Howard S Roth, Antonella Mangraviti, Paul J Hergenrother

Oncotarget· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthesis of [5,6]-Bicyclic Heterocycles with a Ring-Junction Nitrogen Atom: Rhodium(III)-Catalyzed C-H Functionalization of Alkenyl Azoles.
Kim Søholm Halskov, Howard S Roth, Jonathan A Ellman

Angew Chem Int Ed Engl· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Derivatives of Procaspase-Activating Compound 1 (PAC-1) and their Anticancer Activities.
Howard S Roth, Paul J Hergenrother

Curr Med Chem· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Combination of Vemurafenib and Procaspase-3 Activation Is Synergistic in Mutant BRAF Melanomas.
Jessie Peh, Timothy M Fan, Kathryn L Wycislo, Howard S Roth, Paul J Hergenrother

Mol Cancer Ther· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Small-Molecule Procaspase-3 Activation Sensitizes Cancer to Treatment with Diverse Chemotherapeutics.
Rachel C Botham, Howard S Roth, Alison P Book, Patrick J Roady, Timothy M Fan, Paul J Hergenrother

ACS Cent Sci· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Removal of Metabolic Liabilities Enables Development of Derivatives of Procaspase-Activating Compound 1 (PAC-1) with Improved Pharmacokinetics.
Howard S Roth, Rachel C Botham, Steven C Schmid, Timothy M Fan, Levent Dirikolu, Paul J Hergenrother

J Med Chem· May 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Parallel synthesis and biological evaluation of 837 analogues of procaspase-activating compound 1 (PAC-1).
Danny C Hsu, Howard S Roth, Diana C West, Rachel C Botham, Chris J Novotny, Paul J Hergenrother

ACS Comb Sci· January 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
N-heterocyclic carbene-catalyzed rearrangements of vinyl sulfones.
Roxanne L Atienza, Howard S Roth, Karl A Scheidt

Chem Sci· June 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
NHC-catalyzed reactions of aryloxyacetaldehydes: a domino elimination/conjugate addition/acylation process for the synthesis of substituted coumarins.
Eric M Phillips, Manabu Wadamoto, Howard S Roth, Andrew W Ott, Karl A Scheidt

Org Lett· January 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term patency of coronary grafts with endoscopically harvested saphenous veins determined by contrast-enhanced electron beam computed tomography.
Zev Davis, Dave Garber, Stanley Clark, Howard Roth, Vincent Bufalino

J Thorac Cardiovasc Surg· March 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis